MedPath

The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker

Not Applicable
Completed
Conditions
Bradycardia
Interventions
Device: Leadless Pacemaker
Registration Number
NCT02030418
Lead Sponsor
Abbott Medical Devices
Brief Summary

Prospective, non-randomized, single-arm, international multicenter, clinical safety and effectiveness of a leadless pacemaker system in patients who are indicated for a VVIR pacemaker.

Following completion of enrollments in the IDE, patients will continue to be enrolled in the continued access phase of the study under the same protocol.

Detailed Description

The purpose of this study is to evaluate the safety and effectiveness of the leadless pacemaker system in treating patients with a slow heart rate or irregular heartbeats. The Nanostim leadless pacemaker provides bradycardia pacing as a pulse generator with built-in battery and electrodes, for permanent implantation in the right ventricle. As a leadless pacemaker, it does not need a connector, pacing lead, or pulse generator pocket, but it has the same operating principles as a conventional pacemaker.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
526
Inclusion Criteria
  1. Subject must have one of the clinical indications before device implant in adherence with Medicare, ACC/AHA/HRS/ESC single chamber pacing guidelines including:

    • Chronic and/or permanent atrial fibrillation with 2 or 3° AV or bifascicular bundle branch block (BBB block), including slow ventricular rates (with or without medication) associated with atrial fibrillation; or
    • Normal sinus rhythm with 2 or 3° AV or BBB block and a low level of physical activity or short expected lifespan (but at least one year); or
    • Sinus bradycardia with infrequent pauses or unexplained syncope with EP findings; and
  2. Subject ≥18 years of age; and

  3. Subject has life expectancy of at least one year; and

  4. Subject is not enrolled in another clinical investigation; and

  5. Subject is willing to comply with clinical investigation procedures and agrees to return for all required follow-up visits, tests, and exams; and

  6. Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent, approved by the IRB; and

  7. Subject is not pregnant and does not plan to get pregnant during the course of the study.

Exclusion Criteria
  1. Subject has pacemaker syndrome, has retrograde VA conduction or suffers a drop in arterial blood pressure with the onset of ventricular pacing; or
  2. Subject is allergic or hypersensitive to <1 mg of dexamethasone sodium phosphate; or
  3. Subject has a mechanical tricuspid valve prosthesis; or
  4. Subject has a pre-existing endocardial pacing or defibrillation leads; or
  5. Subject has current implantation of either conventional or subcutaneous implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT); or
  6. Subject has an implanted vena cava filter; or
  7. Subject has evidence of thrombosis in one of the veins used for access during the procedure; or
  8. Subject has an implanted leadless cardiac pacemaker; or
  9. Subject had recent cardiovascular or peripheral vascular surgery within 30 days of enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Leadless PacemakerLeadless PacemakerVVIR pacing
Primary Outcome Measures
NameTimeMethod
Pacing thresholds and R-wave amplitudes within the therapeutic range6 months
Complication-Free Rate6 months
Secondary Outcome Measures
NameTimeMethod
appropriate and proportional rate response during graded exercise testing3-6 months

Trial Locations

Locations (59)

El Camino Hospital

🇺🇸

Mountain View, California, United States

Premier Cardiology, Inc

🇺🇸

Newport Beach, California, United States

University of Chicago

🇺🇸

Chicago, Illinois, United States

Huntington Memorial Hospital

🇺🇸

Pasadena, California, United States

WellSpan Health

🇺🇸

York, Pennsylvania, United States

Vancouver General Hospital (U of BC)

🇨🇦

Vancouver, British Columbia, Canada

Princess Alexandra Hospital

🇦🇺

Woolloongabba, Queensland, Australia

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

University Hospitals of Cleveland

🇺🇸

Cleveland, Ohio, United States

Integris Baptist Medical Center

🇺🇸

Oklahoma City, Oklahoma, United States

St. John Hospital and Medical Center

🇺🇸

Detroit, Michigan, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

The Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Memorial Hermann Hospital

🇺🇸

Houston, Texas, United States

Heart Center Research, LLC.

🇺🇸

Huntsville, Alabama, United States

University Hospital - Univ. of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

USC University Hospital

🇺🇸

Los Angeles, California, United States

Scripps Health

🇺🇸

La Jolla, California, United States

Sequoia Hospital

🇺🇸

Redwood City, California, United States

Naples Community Hospital

🇺🇸

Naples, Florida, United States

South Denver Cardiology Associates PC

🇺🇸

Littleton, Colorado, United States

Piedmont Athens Regional Medical Center

🇺🇸

Athens, Georgia, United States

Parkview Research Center

🇺🇸

Fort Wayne, Indiana, United States

Redmond Regional Medical Center

🇺🇸

Rome, Georgia, United States

St. Elizabeth Medical Center

🇺🇸

Edgewood, Kentucky, United States

Advocate Christ Medical Center

🇺🇸

Oak Lawn, Illinois, United States

Kansas University Medical Center

🇺🇸

Kansas City, Kansas, United States

Lahey Clinic Medical Center

🇺🇸

Burlington, Massachusetts, United States

Sparrow Research

🇺🇸

Lansing, Michigan, United States

Munson Medical Center

🇺🇸

Traverse, Michigan, United States

Michigan Heart

🇺🇸

Ypsilanti, Michigan, United States

Fairview Southdale Hospital

🇺🇸

Edina, Minnesota, United States

Mercy Hospital St. Louis

🇺🇸

Saint Louis, Missouri, United States

Jersey Shore University Medical Center

🇺🇸

Neptune, New Jersey, United States

New York Presbyterian Hospital/Cornell University

🇺🇸

New York, New York, United States

Cardiac Arrhythmia and Pacemaker Center

🇺🇸

Roslyn, New York, United States

Cone Health Medical Group HeartCare

🇺🇸

Greensboro, North Carolina, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Methodist University Hospital

🇺🇸

Memphis, Tennessee, United States

South Texas Cardiovascular Consultants

🇺🇸

San Antonio, Texas, United States

Clinical Tex Research, LLC

🇺🇸

Amarillo, Texas, United States

Intermountain Heart Rhythm Specialists

🇺🇸

Murray, Utah, United States

Inova Fairfax Hospital

🇺🇸

Falls Church, Virginia, United States

The Prince Charles Hospital

🇦🇺

Chermside, Queensland, Australia

Royal Adelaide Hospital

🇦🇺

Adelaide, South Australia, Australia

Foothills Medical Centre

🇨🇦

Calgary, Alberta, Canada

Kinsgston General Hospital

🇨🇦

Kingston, Ontario, Canada

Institut de Cardiologie de Quebec (Hospital Laval)

🇨🇦

Quebec, Canada

Institut de Cardiologie de Montreal (Montreal Heart Inst.)

🇨🇦

Montreal, Quebec, Canada

Southlake Regional Health Centre

🇨🇦

Newmarket, Ontario, Canada

Mount Sinai Hospital

🇺🇸

New York, New York, United States

Mercy Medical Group - Cardiology

🇺🇸

Sacramento, California, United States

AdventHealth Orlando

🇺🇸

Orlando, Florida, United States

Orlando Health

🇺🇸

Orlando, Florida, United States

Baptist Health Lexington

🇺🇸

Lexington, Kentucky, United States

Ochsner Medical Center

🇺🇸

New Orleans, Louisiana, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Aurora Medical Group

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath